Alterations in the Expression of the Cell Cycle Regulatory Protein Cyclin Kinase Subunit 1 in Colorectal Carcinoma: Relation to p27Kip1 and its Ubiquitin Ligase Subunit, S Phase Kinase Protein 2

Cancer

Volumn 100, Issue 8, 2004, Pages 1615-1621

  Shapira, Ma'anit ^a   Ben Izhak, Ofer ^a   Bishara, Bishara ^a   Futerman, Boris ^a   Minkov, Ira ^a   Krausz, Michael M ^a   Pagano, Michele ^b   Hershko, Dan D ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NEW YORK UNIVERSITY   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Colorectal carcinoma; Cyclin kinase subunit 1; p27Kip1; S phase kinase protein 2; Ubiquitin

Indexed keywords

CYCLIN KINASE SUBUNIT 1; FORMALDEHYDE; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN KINASE; PROTEIN P27; PYROXYLIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; ENZYME SUBUNIT; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; CARCINOMA; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; S-PHASE KINASE-ASSOCIATED PROTEINS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 1842477477     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20172     Document Type: Article

References (19)

1. Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin dependent kinase inhibitors in human cancer. Annu Rev Med. 1999;50:401-423.
2. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1512.
3. Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995;269:682-685.
4. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425-479.
5. Deshaies RJ. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol. 1999;15:435-467.
6. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1:193-199.
7. Sutterluty H, Chatelain E, Marti A, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol. 1999;1:207-214.
8. Hershko D, Bornstein G, Ben-Izhak O, et al. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 2001;91:1745-1751.
9. Yang G, Ayala G, De Marzo A, et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res. 2002;8:3419-3426.
10. Signoretti S, Di Marcotullio L, Richardson A, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 2002;110:633-641.
11. Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A. 2001;98:5043-5048.
12. Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takashi T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 2001;61:7044-7047.
13. Dowen SE, Scott A, Mukherjee G, Stanley MA. Overexpression of Skp2 does not correlate inversely with p27 expression. Int J Cancer. 2003;105:326-330.
14. Hadwiger JA, Wittenberg C, Mendenhall MD, Reed SI. The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex. Mol Cell Biol. 1989;9:2034-2041.
15. Skp2-mediated ubiquitinylation of p27. Nat Cell Biol. 2001;3:321-324.
16. Kip1. Mol Cell. 2001;7:639-650.
17. Bartek L, Lukas J. p27 destruction: Cks1 pulls the trigger. Nat Cell Biol. 2001;3:E95-E98.
18. Beahrs OH, Henson DE, Hutter RV, Kennedy BJ, editors. AJCC cancer staging manual (4th edition). Philadelphia: Lippincott-Raven, 1992.
19. Inui N, Kitagawa K, Miwa S, et al. High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun. 2003;303:978-984.